The Division of Pediatric Endocrinology and Diabetes at Stanford is actively involved in clinical research. The department has several on-going studies, as well as studies open for enrollment. If you are interested in being contacted about future studies, please complete the Patient List Research Consent Form. Once completed and submitted, the information you provide will be added to our database of potential research participants.
Studies Currently Recruiting
Project ECHO is a collaborative partnership between community providers, Stanford Children’s Health and the University of Florida that enables clinicians to provide better care to more people in their local communities.
The TrialNet research team is currently enrolling for a variety of Type 1 Diabetes studies, including risk screenings, prevention, and more. For additional information, visit www.trialnet.org.
This study, designed for patients using multiple daily injections (MDI), is evaluating the inControl Advice system from TypeZero, which includes smart insulin pens, a Dexcom G5, and an Android phone with the TypeZero inControl algorithm. Learn More
CGM at Diagnosis
This study examines the impact of continuous glucose monitoring (CGM) on families with newly diagnosed children with type 1 diabetes. Learn more
This study is testing the TypeZero closed loop algorithm on a Roche pump in patients 14 and older.
Remote Monitoring of Children with CGM
This study examines the impact of a continuous glucose monitoring (CGM) intervention with the hopes of better understanding how to support parents of young children with diabetes. Learn more
T1D and Bone Health
This study seeks further understanding on how bone and muscle health are affected by Type 1 diabetes. Learn more
The aim of the Pediatric Diabetes Consortium Type 2 Diabetes (T2D) Registry is to develop and utilize a common data
repository to assess treatment approaches for children and youth with
new-onset type 2 diabetes. Learn more
General CGM Use
Patients who use a continuous glucose monitor (CGM) or are interested in using one may enroll in this study to assist clinicians in better understanding general CGM use. Learn more
This is an IRB approved protocol to allow Stanford to do some tests required of OUTSIDE protocols here at Stanford when appropriate. Learn more
Studies Closed for Recruitment
Extended Wear Infusion Set
The Type 1 Diabetes Exchange aims to develop and utilize a common data repository to assess treatment approaches for patients with Type 1 Diabetes.
Medtronic 670G Adolescents and Adults
A safety evaluation of the Medtronic 670G Hybrid Closed Loop System in adolescent and adult patients with Type 1 Diabetes.
Medtronic 670G Pediatric
A safety evaluation of the Medtronic 670G Hybrid Closed Loop System in pediatric patients with Type 1 Diabetes.
This study aims to evaluate the effect of high blood sugar on the brain of pediatric patients with diabetes by comparing MRI results and glucose trends over time.
PHM3 Overnight Closed Loop
The purpose of this study is to assess the safety of a modified algorithm that will give insulin to minimize projected high blood sugar overnight in addition to suspending the pump if low blood sugar is projected overnight in the home environment.
Stanford Diabetes Research Center
The SDRC promotes the teaching and training goals of Stanford University by training the next generation of investigators and leaders of diabetes research and care.
The aim of our basic science program is to elucidate the role of the endocrine system in both health and the development of diseases. Through this work, we hope to increase our understanding of the important physiological processes that are controlled by hormones and how alterations in hormone levels perturb the body’s homeostasis and cause disease in people. Our goal is to apply discoveries we make in the laboratory toward the development of novel therapeutics for a variety of illnesses that affect children. In particular, the laboratory of Dr. Brian Feldman, M.D., Ph.D. studies the impact of the endocrine system on stem cells. Discoveries made in his laboratory have enhanced our understanding of how glucocorticoid hormones work in the body and have generated opportunities to develop novel therapies for a variety of diseases including diabetes and cancer.
Join our database to receive study recruitment emails